27th Apr 2005 10:32
Akers Biosciences, Inc.27 April 2005 AKERS BIOSCIENCES, INC. DIRECTOR'S DEALING Akers Biosciences, Inc. ("the Company") today announces that on 26 April 2005,David Wilbraham, non-executive chairman, purchased 50,000 shares of theCompany's common stock, no par value, at 49 pence per share. Following this purchase, Mr. Wilbraham is the beneficial owner of 300,000 commonshares representing 0.63% of the issued capital Contact: Paul B. Freedman - 00 1 856 848 2116 27 April 2005 End This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
AKR.L